Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | P2RX7 | Q99572 | 14/20 | 0.45 |
| ▸ | TACR3 | P29371 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4988057 | 0.87 | P2RX7 (0.45) | HPGDP2RX7 | |
| SCHEMBL4992289 | 0.86 | GRM5 (0.49) | HPGDPKMP2RX7 | |
| SCHEMBL4984765 | 0.86 | P2RX7 (0.44) | P2RX7 | |
| SCHEMBL4988859 | 0.84 | P2RX7 (0.43) | P2RX7 | |
| SCHEMBL4984815 | 0.84 | GRM5 (0.48) | P2RX7TACR3 | |
| SCHEMBL4985119 | 0.84 | HPGD (0.57) | HPGDP2RX7 | |
| SCHEMBL4988578 | 0.83 | TSHR (0.47) | HPGDP2RX7 | |
| SCHEMBL4982979 | 0.82 | GRM5 (0.50) | P2RX7 | |
| SCHEMBL4990817 | 0.82 | PKM (0.46) | HPGDPKMP2RX7TACR3 | |
| SCHEMBL4985624 | 0.82 | P2RX7 (0.49) | HPGDP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080039478-A1 | Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof | RENOVIS, INC. | 2008-02-14 | — | — | US | claimed |
| US-7297700-B2 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof | RENOVIS, INC. (US) | 2007-11-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039478-A1 | Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof | P2RX7, P2RX3, P2RX2 | HPGD 368/4885PKM 1098/4885P2RX7 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.